^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    vosilasarm (EP0062)

    i
    Company:
    Ellipses Pharma, Radius
    Drug class:
    Selective androgen receptor modulator
    Related drugs:
    Apply
    Phase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer (NCT05573126)
    Phase 1/2
    Ellipses Pharma
    Recruiting
    Last update posted :
    02/21/2025
    Initiation :
    01/11/2023
    Primary completion :
    11/01/2025
    Completion :
    11/01/2026
    HER-2
    |
    HER-2 negative
    |
    everolimus • Orserdu (elacestrant) • vosilasarm (EP0062)